Zocor and Ileus paralytic - a phase IV clinical study of FDA data

Summary:

Ileus paralytic is reported as a side effect among people who take Zocor (simvastatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Lasix, and have Primary progressive multiple sclerosis.

The phase IV clinical study analyzes which people have Ileus paralytic when taking Zocor. It is created by eHealthMe based on reports of 84,616 people who have side effects when taking Zocor from the FDA, and is updated regularly.

What is Zocor?

Zocor has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 86,545 Zocor users. Check the latest studies of Zocor.

What is Ileus paralytic?

Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles) is found to be associated with 686 drugs and 849 conditions by eHealthMe. Check the latest studies of Ileus paralytic.

On Jul, 11, 2026

84,616 people reported to have side effects when taking Zocor.
Among them, 62 people (0.07%) have Ileus paralytic.

Among these 62 people:

How long have people been on Zocor when they have Ileus paralytic? *

What is the gender of people who have Ileus paralytic when taking Zocor? *

female: 50 %
male: 50 %

What is the age of people who have Ileus paralytic when taking Zocor? *

What are other drugs people take besides Zocor? *

What are other side effects people have besides Ileus paralytic? *

Nausea And Vomiting: 25 people, 40.32%
Pain: 22 people, 35.48%
Nausea (feeling of having an urge to vomit): 22 people, 35.48%
Fatigue (feeling of tiredness): 21 people, 33.87%
Pneumonia: 20 people, 32.26%
Joint Pain: 18 people, 29.03%
Constipation: 18 people, 29.03%
Dehydration (dryness resulting from the removal of water): 18 people, 29.03%
Acute Kidney Failure: 18 people, 29.03%
Stress And Anxiety: 16 people, 25.81%

What are the existing conditions these people have? *

Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 12.90%
Bone Neoplasm Malignant (cancer of bone): 7 people, 11.29%
Nausea (feeling of having an urge to vomit): 6 people, 9.68%
Multiple Myeloma (cancer of the plasma cells): 4 people, 6.45%
Urinary Tract Infection: 2 people, 3.23%
Irritable Bowel Syndrome: 2 people, 3.23%
Constipation: 2 people, 3.23%
Colon Cancer: 2 people, 3.23%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 1 person, 1.61%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 1.61%

* Approximation only. Some reports may have incomplete information.

Do you take Zocor and have Ileus paralytic?

- Check whether Ileus paralytic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zocor:

Zocor (86,545 reports)

Ileus paralytic treatments and more:

Ileus paralytic (6,720 reports)

Browse all side effects of Zocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ileus paralytic:

Ileus paralytic (686 drugs)

Browse all the conditions that are associated with Ileus paralytic:

Ileus paralytic (849 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Zocor) and Zocor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.